)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
BioRestorative Therapies
BioRestorative Therapies (BRTX) investor relations material
BioRestorative Therapies Registration Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration Filing summary10 Feb, 2026
Management team and governance
President, CEO, and Chairman is Lance Alstodt; other key officers include Francisco Silva (VP, R&D), Robert E. Kristal (CFO), Nickolay Kukekov, Patrick F. Williams, and David Rosa as directors.
Executive and incentive stock option agreements are in place for senior management, with recent awards dated through February 2025.
Offering details and pricing
Placement involves registered shares of common stock or pre-funded warrants, and warrants to purchase common stock.
Terms of the placement, including pricing, are to be mutually agreed upon by the company, placement agent, and purchasers.
Placement agent receives a 7% cash fee on gross proceeds and warrants equal to 7% of the total shares and pre-funded warrants sold, exercisable at 125% of the public offering price.
Placement agent may be reimbursed up to $100,000 for expenses upon closing.
Underwriters and syndicate
Rodman & Renshaw LLC serves as exclusive placement agent on a reasonable best efforts basis.
Placement agent may retain sub-agents or selected dealers.
Placement agent is a FINRA member and registered broker/dealer.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from BioRestorative Therapies
- BRTX-100 advances in Phase 2 with FDA Fast Track, targeting spine and metabolic markets.BRTX
Investor presentation10 Feb 2026 - IPO seeks up to $10M for cell therapy clinical trials amid ongoing losses and high risk.BRTXRegistration Filing9 Feb 2026
- Q3 2024 delivered 70% BRTX-100 response, revenue growth, and strong liquidity, but more funding needed.BRTXQ3 202414 Jan 2026
- Revenue up 175% with major FDA milestones and strong cash reserves, advancing cell therapy pipeline.BRTXQ4 202427 Dec 2025
- FDA cleared phase II cervical trial for BRTX-100, expanding pipeline and expediting development.BRTXStatus Update26 Dec 2025
- Shareholders will vote on director election, equity plan expansion, and auditor ratification.BRTXProxy Filing2 Dec 2025
- Annual meeting to vote on directors, stock plan amendment, auditor, and executive pay.BRTXProxy Filing2 Dec 2025
- Q1 2025 saw a $5.3M net loss, strong cash, and key FDA milestones amid liquidity concerns.BRTXQ1 202525 Nov 2025
- Q2 revenue up 240% with clinical progress, but liquidity risks remain.BRTXQ2 202523 Nov 2025
Next BioRestorative Therapies earnings date
Q4 202527 Mar, 2026
BioRestorative Therapies
Next BioRestorative Therapies earnings date
Q4 202527 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage